Prometheus Biosciences Inc.

RXDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$199.92

+$0.18 (+0.09%)

At close: Jun 15, 2023, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

0.09%

(1Y)

Key Statistics

Market Data

Market Cap $9.56B

1D Range

199.92 199.96

52W Range

23.27 199.96

Valuation (TTM)

PE -57.28

PB 13.70

EV/EBITDA -55.25

Valuation (NTM)

Forward PE N/A

Forward PEG 2.75

Price Target $138.57

Cash Flow

FCF Yield -1.4%

SBC Adj. FCF Yield -1.7%

SBC Impact -19.9%

Margins

Gross Margin 100.0%

Operating Margin -4064.7%

FCF Margin -3396.4%

Growth (CAGR)

Revenue 3Y | 5Y 159.7% | 57.2%

Dil EPS 3Y | 5Y -43.9% | -17.8%

FCF 3Y | 5Y -55.4% | -22.3%

Returns

ROA -19.1%

ROE -31.1%

ROIC -20.2%

Financial Health

Net Cash

$684.21M

Current Ratio 31.04

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.